Market Research Logo

Respiratory/Pulmonary Market Research Reports & Industry Analysis


Filter your search

Research Assistance

Join Alert Me Now!

Sign Up

Find out more on our blog

Respiratory/Pulmonary Industry Research & Market Reports

  • Global Respiratory Syncytial Virus (RSV)Testing Market Future Horizons and Growth Strategies: Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging Opportunities

    ...the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Respiratory Syncytial Virus definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by ... Read More

  • Lung Cancer: Analytical Tool

    ...development, drug development or investment perspective. BioSeeker’s Analytical Tools have proven their worth to our clients in oncology for almost two decades in their capacities covering: Target Scouting Early & Late Stage Pipeline Analysis Biomarker/Companion ... Read More

  • Global Lung Cancer Therapeutics Market Report 2016

    ...and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Lung Cancer Therapeutics basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing ... Read More

  • Pulmonary Embolism - Pipeline Review, H2 2016

    ...therapeutics under development for Pulmonary Embolism, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of ... Read More

  • Global Respiratory Syncytial Virus (RSV) Diagnostic Market Report 2016

    ...regions (North America, Europe and Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Respiratory Syncytial Virus (RSV) Diagnostic basics: definitions, classifications, applications and industry chain overview; industry ... Read More

  • Severe Acute Respiratory Syndrome (SARS) - Pipeline Review, H2 2016

    ...pipeline landscape. The report provides comprehensive information on the therapeutics under development for Severe Acute Respiratory Syndrome (SARS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) ... Read More

  • Lung Cancer Drug Pathway Analyzer

    ...plethora of treatment strategies is based on our increasing understanding of the 393 drug targets that are included in this drug-pathway analyzing tool. No less than 369 of these have been recorded with mutations and ... Read More

  • Target Atlas in Lung Cancer: A Competitive Outlook

    ...Target Approaches in development today from your competitors and prospective partners and revealing the areas where your company can succeed. "Target Atlas in Lung Cancer: A Competitive Outlook" is a one-of-a-kind, authoritative target analyzer tool, ... Read More

  • Global Respiratory System Market Research Report 2016

    ...Asia) and the main countries (United States, Germany, Japan and China). The report firstly introduced the Respiratory System basics: definitions, classifications, applications and industry chain overview; industry policies and plans; product specifications; manufacturing processes; cost ... Read More

  • Pulmonary Embolism-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Pulmonary Hypertension-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Severe Acute Respiratory Syndrome (SARS) Coronavirus Infection-Pipeline Insights, 2016

    ...The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including ... Read More

  • Global Respiratory Care Devices Market Analysis 2016 - Forecast to 2022

    ...data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation ... Read More

  • Acute Lung Injury-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Bronchitis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Chronic Thromboembolic Pulmonary Hypertension-Pipeline Insights, 2016

    ...in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent ... Read More

  • Cough-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Lung Adenocarcinoma-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD)-Pipeline Insights, 2016

    ...Disease (PVD). The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development ... Read More

  • Pertussis-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Pulmonary Arterial Hypertension-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

  • Chronic Bronchitis-Pipeline Insights, 2016

    ...development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA ... Read More

  • Emphysema-Pipeline Insights, 2016

    ...Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. ... Read More

  • Global Respiratory Drugs Market to 2022 - Pipeline and Market Characterized by Growing Prominence of Targeted Therapies, with Asthma and Cystic Fibrosis Leading the Way

    ...affect the respiratory system in different ways, such as the scarring of lung tissue, and excessive production of mucus in the airways, thereby decreasing lung function. Some of the key indications in this therapy area ... Read More

  • Idiopathic Pulmonary Fibrosis-Pipeline Insights, 2016

    ...stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA ... Read More

1 3 5 6 7 8 9 10